Humalog 25% Lispro, 75% Npl



Indications and Reactions:

Role Indications Reactions
Primary
Diabetes Mellitus 40.8%
Type 2 Diabetes Mellitus 28.0%
Hypertension 7.5%
Gestational Diabetes 4.7%
Type 1 Diabetes Mellitus 4.0%
Blood Cholesterol 1.9%
Insomnia 1.9%
Anticoagulant Therapy 1.2%
Hypothyroidism 1.2%
Pain 1.2%
Blood Cholesterol Abnormal 0.9%
Blood Pressure 0.9%
Blood Pressure Abnormal 0.9%
Product Used For Unknown Indication 0.9%
Ascites 0.6%
Blood Glucose Increased 0.6%
Cardiac Disorder 0.6%
Depression 0.6%
Diuretic Therapy 0.6%
Fibromyalgia 0.6%
Death 9.5%
Exposure During Pregnancy 6.8%
Pneumonia 6.8%
Premature Baby 6.8%
Visual Impairment 6.8%
Drug Ineffective 5.4%
Myocardial Infarction 5.4%
Visual Acuity Reduced 5.4%
Vomiting 5.4%
Blindness 4.1%
Blood Glucose Increased 4.1%
Hyperglycaemia 4.1%
Hypertension 4.1%
Hypoglycaemic Unconsciousness 4.1%
Renal Failure Chronic 4.1%
Underdose 4.1%
Urinary Tract Infection 4.1%
Urticaria 4.1%
Cataract 2.7%
Cerebrovascular Accident 2.7%
Secondary
Type 2 Diabetes Mellitus 32.4%
Diabetes Mellitus 30.3%
Hypertension 9.0%
Gestational Diabetes 5.4%
Type 1 Diabetes Mellitus 4.5%
Insomnia 3.6%
Ascites 1.8%
Blood Cholesterol 1.5%
Blood Pressure 1.5%
Pain 1.5%
Depression 1.2%
Hypoglycaemia 1.2%
Hypovitaminosis 1.2%
Cardiac Disorder 0.9%
Diabetic Neuropathy 0.9%
Anticoagulant Therapy 0.6%
Blood Cholesterol Abnormal 0.6%
Blood Pressure Abnormal 0.6%
Diuretic Therapy 0.6%
Gastrooesophageal Reflux Disease 0.6%
Spinal Osteoarthritis 10.0%
Weight Increased 10.0%
Premature Baby 7.8%
Wrong Drug Administered 7.8%
Weight Decreased 6.7%
Hypoglycaemia 5.6%
Pneumonia 5.6%
Visual Impairment 5.6%
Road Traffic Accident 4.4%
Blood Glucose Increased 3.3%
Diabetes Mellitus Inadequate Control 3.3%
Drug Ineffective 3.3%
Foot Fracture 3.3%
Hyperglycaemia 3.3%
Hypertension 3.3%
Hypoglycaemic Unconsciousness 3.3%
Liver Disorder 3.3%
Loss Of Consciousness 3.3%
Malaise 3.3%
Mitral Valve Incompetence 3.3%
Concomitant
Diabetes Mellitus 75.0%
Type 2 Diabetes Mellitus 25.0%
Death 33.3%
Toxic Nodular Goitre 33.3%
Visual Impairment 33.3%